ArticleNature biotechnology2015

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

Isaac B Hilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.